Related Experiment Video
Updated: Sep 7, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
COVID-19 complicated by infective endocarditis or concomitant infection? a case report
Chaymae Miri1, Falmata Laouan Brem1, Hammam Rasras1
1Department of Cardiology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University, Oujda, Maroc.
Insights
This case report details a patient with infective endocarditis, a serious heart valve infection, who also had Coronavirus disease 2019 (COVID-19). The findings suggest COVID-19 may increase the risk and complicate the prognosis of infective endocarditis.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) is a global pandemic with significant cardiovascular implications.
- Cardiovascular complications are linked to poorer COVID-19 prognosis.
- COVID-19 may be a risk and prognostic factor for infective endocarditis.
Observation:
- A 53-year-old woman with persistent cough, dyspnea, and fatigue, diagnosed with COVID-19 four weeks prior.
- Clinical presentation, radiological, and analytical data confirmed infective endocarditis of the mitral valve.
- Initial treatment included azithromycin and corticosteroids, followed by Teicoplanin and gentamicin during hospitalization.
Findings:
- Successful treatment of mitral valve infective endocarditis was achieved with antibiotics.
- Transthoracic echocardiograms showed the disappearance of the vegetative lesion.
- The patient experienced a good clinical outcome.
Implications:
- This case underscores the importance of considering coexisting diagnoses, such as infective endocarditis, in patients with COVID-19.
- Highlights the need for vigilance regarding potential cardiovascular complications in COVID-19 patients.
- Suggests a potential link between COVID-19 and the development or exacerbation of infective endocarditis.
Abstract:
Coronavirus disease 2019 (COVID-19) is a global pandemic and public health emergency. With a high infectivity and dissemination rate, cardiovascular complications have been observed and associated with a poorer prognosis. COVID-19 appears to be both a risk and prognosis factor for infective endocarditis. In this report, we present the case of a 53-year-old woman with a non-productive cough, progressive dyspnea and fatigue, diagnosed with COVID-19 four weeks earlier. The patient was referred to our department displaying the same symptoms. She was diagnosed with infective endocarditis of the mitral valve based on clinical symptoms, as well as radiological and analytical investigations. The patient was given appropriate medical treatment before admission based on azithromycin, corticosteroids for two weeks, during the hospitalization, she underwent treatment with antibiotics based on Teicoplanin and gentamicin. Outcome was good; the disappearance of the vegetative lesion on the weekly transthoracic echocardiogram (TTE). This rare case highlights questions about considering other coexisting diagnoses as well as possible complications a long with COVID-19.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis III: Medical Management
Pericarditis I: Introduction

